• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Scientific Publications by FDA Staff

  • Print
  • Share
  • E-mail

Search Publications



Starting Date

Ending Date

Order by

Entry Details

J Thyroid Res 2014;2014:710178

The hypothalamic-pituitary-thyroid axis in infants and children: protection from radioiodines.

Fisher J, Yang X, Harris C, Koturbash I, Lumen A


Potassium iodide (KI) is recommended as an emergency treatment for exposure to radioiodines, most commonly associated with nuclear detonation or mishaps at nuclear power plants. Protecting the thyroid gland of infants and children remains a priority because of increased incidence of thyroid cancer in the young exposed to radioiodines (such as (131)I and (133)I). There is a lack of clinical studies for KI and radioiodines in children or infants to draw definitive conclusions about the effectiveness and safety of KI administration in the young. In this paper, we compare functional aspects of the hypothalamic-pituitary-thyroid (HPT) axis in the young and adults and review the limited studies of KI in children. The HPT axis in the infant and child is hyperactive and therefore will respond less effectively to KI treatment compared to adults. Research on the safety and efficacy of KI in infants and children is needed.

Category: Journal Article
PubMed ID: #24971190 DOI: 10.1155/2014/710178
PubMed Central ID: #PMC4058186
Includes FDA Authors from Scientific Area(s): Toxicological Research
Entry Created: 2014-06-28